UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
In landmark single-cell study of pancreatic tumors, UC San Diego Moores Cancer Center researchers reveal how tumor evolution shapes disease, which could yield new, more effective treatments for one of the deadliest cancers.
A new PRIME program at UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences will train the next generation of pharmacy leaders to work in underserved areas.
InflammaSense’s wearable VITALx-patch sensor will monitor patients’ immune responses in real time as part of a federal initiative.
UC San Diego has retained its title as the No. 1 public research university in the nation, according to Washington Monthly's 2026 College Guide and Rankings “America’s Best Colleges for Research.” It also retained its No. 6 ranking among all research universities in the U.S.
Jacobs Retina Center at UC San Diego unites clinicians, engineers and scientists to turn retinal discoveries into treatments, advancing vision care through AI, genetics and translational research.
Statins, which are commonly prescribed to lower cholesterol, could help protect the eyes against glaucoma, says new research from UC San Diego.
Medical News Today, October 12
KNX Radio (Los Angeles), October 8
Medical Daily, October 7
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
